The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...
Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC ...
The H5N1 bird flu outbreak in the U.S. has so far been shockingly mild. Researchers have some theories as to why.
Some of the 20 largest U.S. restaurant chains have received failing grades when it comes to adopting policies for restricting ...
There's growing interest in radiopharmaceuticals. But a "significant talent shortage" may threaten the field's rise.
Perkins is the director of Health Policy Strategy at the Center for Advancing Health Policy through Research (CAHPR) at the ...